The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

S hares of Hims & Hers (NYSE: HIMS) fell as much as 15% on Thursday after news that Eli Lilly's (NYSE: LLY) GLP-1 drug was taken off the shortage list by the FDA. This could impac ...

The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...

Levi Strauss & Co.’s (LEVI) shares plunged 7.7% after reporting third-quarter fiscal 2024 net revenues of $1,517 million, missing the Zacks Consensus Estimate of $1,552 million. Shares of ...

But a growing number of users have had serious health effects. Our reporting found that some widely held beliefs about the drug’s safety aren’t true → Megan Twohey It’s a myth, for ...

03 October 2024, 13:14 Sources to Al-Arabiya: At least four Israeli soldiers have been killed and 15 others injured in two operations on the Lebanese border. 03 October 2024, 13:07 The Israeli army ...

The Syfy series will be hitting Netflix in Canada and a handful of other territories in October.